Valuation: InterCure Ltd.

Market Cap 129M 40.58B 115M 106M 96.07M 182M 12.08B 187M 1.27B 505M 6.47B 484M 473M 20.37B P/E 2024
-4.01x
P/E 2025 -4.87x
Enterprise Value 265M 83.51B 237M 218M 198M 375M 24.86B 384M 2.61B 1.04B 13.31B 995M 974M 41.92B EV / Sales 2024
1.69x
EV / Sales 2025 1.16x
Free-Float
61.79%
Yield 2024 *
-
Yield 2025 -
1 day+4.02%
1 week-16.88%
Current month-20.53%
1 month-32.92%
3 months-26.46%
6 months-13.65%
Current year-32.76%
1 week 1,001
Extreme 1001
1,275
1 month 1,001
Extreme 1001
1,599
Current year 1,001
Extreme 1001
1,862
1 year 1,001
Extreme 1001
2,371.5
3 years 1,001
Extreme 1001
6,730
5 years 1,001
Extreme 1001
13,175
10 years 734.13
Extreme 734.1278
31,589.75
Manager TitleAgeSince
Chief Executive Officer 55 23/12/2019
Director of Finance/CFO 47 29/02/2020
General Counsel - 31/03/2022
Director TitleAgeSince
Director/Board Member 50 02/09/2015
Director/Board Member 67 13/12/2014
Chairman 55 12/02/2025
Date Insider Type Main position Quantity % Market Cap. Importance
18/03/26 Other

Chief Financial Officer

539,947 0.9874%
18/03/26 Other

Director

19,046 0.0348%
18/03/26 Other

Chief Executive Officer

17,285,455 31.6113%
Change 5-day change 1-year change 3-year change Capi.($)
+4.02%-16.88%-52.60%-49.14% 40.78M
+1.67%-3.68%+7.93%+27.73% 109B
+2.00%+7.94%+5.93%+121.87% 105B
+3.13%-15.45%+60.54%+605.86% 46.46B
+0.47%+8.03%+10.16%+105.72% 33.1B
+1.43%+4.57%+47.13%+82.02% 30.19B
+1.58%+3.53%+44.66%+97.26% 28.57B
+2.00%+7.48%+40.80%+448.80% 23B
+0.84%+3.30%-17.28%-17.22% 19.97B
+0.52%-0.26%-5.84%+31.41% 16.76B
Average +1.76%-0.52%+14.14%+145.43% 41B
Weighted average by Cap. +1.73%+0.93%+18.98%+153.36%

Financials

2024 2025
Net sales 239M 75.21B 213M 196M 178M 337M 22.39B 346M 2.35B 935M 11.99B 896M 877M 37.75B 270M 85.08B 241M 222M 201M 382M 25.33B 391M 2.65B 1.06B 13.56B 1.01B 992M 42.71B
Net income -67.8M -21.35B -60.51M -55.68M -50.54M -95.78M -6.35B -98.15M -666M -265M -3.4B -254M -249M -10.72B -35.71M -11.24B -31.87M -29.33M -26.62M -50.45M -3.35B -51.7M -351M -140M -1.79B -134M -131M -5.64B
Net Debt 133M 41.8B 118M 109M 98.96M 188M 12.44B 192M 1.3B 520M 6.66B 498M 488M 20.98B 136M 42.93B 122M 112M 102M 193M 12.78B 197M 1.34B 534M 6.84B 512M 501M 21.55B
Projected Income Statement - Annual - InterCure Ltd.
Logo InterCure Ltd.
InterCure Ltd. is an Israel-based company engaged in the medical cannabis industry. Through its wholly owned subsidiary, Canndoc Ltd., the Company cultivates, produces, processes, markets, and distributes medical cannabis products. Its operations include the development and manufacture of pharmaceutical-grade medical cannabis products produced in accordance with Good Manufacturing Practice (GMP) standards. The Company offers a range of cannabis-based products for medical use and operates across various stages of the medical cannabis value chain, including cultivation, manufacturing, logistics, distribution, and retail activities. In addition, the Company is involved in the import, export, and commercialization of medical cannabis products and related healthcare solutions in Israel and selected international markets.
Employees
285
Date Price Change Volume
09/11/26 ILA 1,088.00 +4.02% 21,284
06/11/26 ILA 1,046.00 -5.85% 15,038
05/11/26 ILA 1,111.00 -6.87% 21,069
04/11/26 ILA 1,193.00 -7.01% 10,044
03/11/26 ILA 1,283.00 -1.99% 5,649
  1. Stock Market
  2. Stocks
  3. INCR Stock